Advice
Following an abbreviated submission
Lansoprazole oro-dispersible tablet (Zoton FasTab) is accepted for use in NHS Scotland, in combination with appropriate antibiotics, for the eradication of Helicobacter pylori from the upper gastrointestinal tract in patients with ulcer-like dyspepsia in whom Helicobacter pylori infection has been demonstrated.
The standard formulation of lansoprazole also has this indication.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Lansoprazole oro-dispersible tablet (Zoton FasTab®)
- SMC ID:
- 229/05
- Indication:
- Eradication of Helicobacter pylori
- Pharmaceutical company
- Wyeth Pharmaceuticals
- BNF chapter
- Gastro-intestinal system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 January 2006